Research and Development

CDSCO Offers Guidance on Approval of Stem Cell/Cell-Based Products

Manufacturers of stem cell and cell-based products (SCCPs) should perform stability tests during early phases of clinical trials to establish the products are sufficiently stable for the period required by the study, a draft guidance by India’s Central Drugs Standard Control Organization advises. Read More